Home › Trial NCT05816538
The Immune Response of Breast Cancer Patients Treated With Levobupivacaine Using Paravertebral or Superficial Chest Blocks
- Trial IDNCT05816538
- StatusActive Not Recruiting
- PhaseN/A
- Study typeInterventional
- SponsorUniversity of Rijeka
- Enrollment100
- Start date2024-01-18
- ConditionsParavertebral Block · Pectoralis and Serratus Plane Nerve Blocks · Breast Cancer · Immunologic Suppression · Levobupivacaine
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.